000			01930 a2200541 4500
005			20250514023834.0
264		0	_c20020520
008			200205s 0 0 eng d
022			_a1021-7401
024	7		_a10.1159/000049024 _2doi
040			_aNLM _beng _cNLM
100	1		_aGhezzi, P
245	0	0	_aTumor necrosis factor and motoneuronal degeneration: an open problem. _h[electronic resource]
260			_bNeuroimmunomodulation _c2001
300			_a178-82 p. _bdigital
500			_aPublication Type: Journal Article; Review
650	0	4	_aAnimals
650	0	4	_aAntibodies, Monoclonal _xadverse effects
650	0	4	_aApoptosis _xdrug effects
650	0	4	_aAutoimmune Diseases _ximmunology
650	0	4	_aCells, Cultured _xdrug effects
650	0	4	_aContraindications
650	0	4	_aDisease Models, Animal
650	0	4	_aEncephalomyelitis, Autoimmune, Experimental _ximmunology
650	0	4	_aGene Expression Regulation _xphysiology
650	0	4	_aHumans
650	0	4	_aInflammation _xmetabolism
650	0	4	_aMice
650	0	4	_aMice, Neurologic Mutants
650	0	4	_aMice, Transgenic
650	0	4	_aMotor Neuron Disease _xenzymology
650	0	4	_aMotor Neurons _xpathology
650	0	4	_aMultiple Sclerosis _ximmunology
650	0	4	_aNF-kappa B _xmetabolism
650	0	4	_aNerve Degeneration _xmetabolism
650	0	4	_aNerve Growth Factors _xpharmacology
650	0	4	_aNeuronal Ceroid-Lipofuscinoses _xgenetics
650	0	4	_aNeuroprotective Agents _xtherapeutic use
650	0	4	_aOxidative Stress
650	0	4	_aRats
650	0	4	_aReceptors, Tumor Necrosis Factor _xdrug effects
650	0	4	_aSignal Transduction
650	0	4	_aSuperoxide Dismutase _xdeficiency
650	0	4	_aTumor Necrosis Factor-alpha _ximmunology
700	1		_aMennini, T
773	0		_tNeuroimmunomodulation _gvol. 9 _gno. 4 _gp. 178-82
856	4	0	_uhttps://doi.org/10.1159/000049024 _zAvailable from publisher's website
999			_c11756044 _d11756044